Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0200
+0.0010 (5.26%)
Sep 11, 2026, 11:24 AM AEST
Botanix Pharmaceuticals Stock Forecast
ASX-BOT's stock price has decreased by -81.82% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Botanix Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $0.48. The average 1-year stock price forecast is 2,300.00% higher than the current stock price, while the lowest is $0.14 (+600.00%) and the highest is $1.00 (+4,900.00%).
Price Target: $0.48 (+2,300.00%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Botanix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $1.00 | Buy | Reiterates | $1.00 | +4,900.00% | Aug 26, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $0.14 | Buy | Maintains | $0.14 | +600.00% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
60.80M
from 33.80M
Increased by 79.87%
Revenue Next Year
118.73M
from 60.80M
Increased by 95.29%
EPS This Year
-0.01
from -0.03
EPS Next Year
n/a
from -0.01
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.